Clinical trials
Phase 2 Ataxia Telangiectasia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2013 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| BioDelivery Sciences International | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| IntraBio Inc | 1 |
| Matrix Biomed, Inc. | 1 |
| Radboud University Medical Center | 1 |
| Sara Elva Espinosa Padilla, MD | 1 |
| The University of Queensland | 1 |
| University Hospital, Akershus | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ataxia Telangiectasia | 8 |
| Ataxia | 1 |
| Blast Crisis | 1 |
| Breast Neoplasms | 1 |
| Burkitt Lymphoma | 1 |
| Carcinoma, Ovarian Epithelial | 1 |
| Congenital Abnormalities | 1 |
| Hereditary Sensory and Autonomic Neuropathies | 1 |
| Hodgkin Disease | 1 |
| Immunoblastic Lymphadenopathy | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.